Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a ba...
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overprice...
Kindred Biosciences (NASDAQ:KIN) reported Q1 sales of $2.40 million. Earnings fell to a loss of $9.17 million, resulting in a 1...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...
Lake Street analyst Brooks O'Neil downgrades Kindred Biosciences (NASDAQ: KIN) from Buy to Hold and lowers the price tar...
This morning 94 companies set new 52-week highs.
HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Kindred Biosciences (NASDAQ: KIN) from Buy to Neutral and ...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...
